Answers are grounded in this paper and cite their sources.
This review highlights improved drug delivery systems in cancer therapy using chitosan and graphene oxide, suggesting enhanced therapeutic interventions.
This review focuses on anticancer drug delivery systems using graphene/chitosan (CS) nanocomposites, and the present discussion explores the potential of chitosan/graphene oxide composites and their applications in wound dressings and drug delivery systems, particularly in cancer therapy. Graphene/chitosan-based drug delivery is gaining popularity due to its unique physical, chemical, and electrical properties, improving drug efficacy. The inherent biodegradability, non-toxicity, and antibacterial properties of chitosan make it a highly promising biopolymer for therapeutic interventions. Researchers have also identified graphene oxide as a non-toxic, cost-effective, and biocompatible material suitable for a diverse range of applications. Therefore, here we will examine the reasons for their use in drug delivery, especially in cancer. In addition, we will also study the combination of these two excellent materials. The combination of chitosan (CS) and graphene is currently under investigation for its enhanced therapeutic benefits.
No takes yet. Share an insight, caveat, or question.
Lavasani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: